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ABSTRACT
Mutations of the Glu76 residue of canonical histone
H2B are frequently found in cancer cells. However,
it is quite mysterious how a single amino acid sub-
stitution in one of the multiple H2B genes affects
cell fate. Here we found that the H2B E76K muta-
tion, in which Glu76 is replaced by Lys (E76K), dis-
torted the interface between H2B and H4 in the nucle-
osome, as revealed by the crystal structure and in-
duced nucleosome instability in vivo and in vitro. Ex-
ogenous production of the H2B E76K mutant robustly
enhanced the colony formation ability of the express-
ing cells, indicating that the H2B E76K mutant has
the potential to promote oncogenic transformation in
the presence of wild-type H2B. We found that other
cancer-associated mutations of histones, H3.1 E97K
and H2A.Z.1 R80C, also induced nucleosome insta-
bility. Interestingly, like the H2B E76K mutant, the
H3.1 E97K mutant was minimally incorporated into
chromatin in cells, but it enhanced the colony for-
mation ability. In contrast, the H2A.Z.1 R80C mutant
was incorporated into chromatin in cells, and had
minor effects on the colony formation ability of the
cells. These characteristics of histones with cancer-
associated mutations may provide important infor-
mation toward understanding how the mutations pro-
mote cancer progression.
INTRODUCTION
The nucleosome is the basic repeating unit of chromatin,
and is composed of two molecules of histones (H2A, H2B,
H3 and H4) and about 150 bp of DNA (1,2). Canoni-
cal types of histones are incorporated into chromatin dur-
ing the S-phase of the cell cycle, in a DNA replication-
dependent manner (3). To ensure the robust production of
the canonical histones during S-phase, multiple copies of
the canonical histone genes exist in the genomes of higher
eukaryotes (4). In addition, non-allelic isoforms of histones
(histone variants) have been identified in many species (5).
In humans, each of the histone variants is encoded by either
a single gene or a few copies of genes (6).
Many mutations in the histone variant genes have been
identified in cancer cells, suggesting that the mutations di-
rectly perturb the function of the corresponding histone
variants (7–9).Mutations of the histone variant H3.3 Lys27
and Gly34 residues, which are located in the disordered N-
terminal tail, have been reported in pediatric gliomas (7,8).
The histone tails function as target sites for themodifier and
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reader proteins for the histone post-translational modifica-
tions (10). Interestingly, the production of the H3.3 K27M
mutant, in which theH3.3 Lys27 residue is replaced byMet,
abrogates the activity of polycomb repressive complex 2
(PRC2), which methylates the H3 Lys27 residue (11). Sim-
ilar inhibition of methyltransferases by the H3 K9M and
K36Mmutations has also been reported (12). The effects of
thesemutations within the histone tails suggest that the Lys-
to-Met substitutions on the target sites for histone methyla-
tion may disturb the proper histone modification landscape
in the epigenome, and thus promote a variety of genomic
disorders.
Curiously, mutations in some of the multiple canonical
histone genes have been identified in human cancer cells
(8,13–16). Many of these mutations occur in the globular
‘histone-fold’ domain. This suggests that these amino acid
substitutions may have a direct impact on the nucleosome
structure, and could abrogate proper gene regulation by the
chromatin architecture (17,18). Therefore, the production
of these canonical histone mutants, which may be partly in-
corporated into chromatin, could dominantly enhance cell
growth and the incidence of cancer-associated mutations,
probably by changing the physical and structural proper-
ties of the nucleosome. However, the impact of the cancer-
associated mutations of canonical histones has not been
studied yet.
Mutations in one of the seventeen H2B genes, especially
HIST1H2BC, HIST1H2BD and HIST1H2BE, have been
dominantly found in cancer cells (13–15). Among them,
mutations of the H2B Glu76 residue are found in can-
cer cells with high frequency. Therefore, in the present
study, we focused on the H2B E76K mutation, in which
the Glu76 residue is replaced by Lys. Our structural and
biochemical analyses revealed that, in the nucleosome, the
H2B E76Kmutation perturbs the interaction between H2B
and H4, and profoundly weakens the association of the
H2A-H2B dimer with the H3-H4 tetramer. We found that
the exogenous production of the H2B E76K mutant ro-
bustly enhances the colony formation ability, mimicking
the dominant phenotype observed in cancer cells. Interest-
ingly, the other cancer-associated mutations found in his-
tonesH3.1 andH2A.Z.1 also induce nucleosome instability.
Remarkably, the H3.1 E97K mutant significantly enhanced
the colony formation ability, although only small amounts
were incorporated into chromatin in cells. In contrast, the
H2A.Z.1 R80C mutant minimally affected the colony for-
mation ability of the cells. Therefore, the cancer-associated
mutations in histones H2B, H3.1 and H2A.Z.1 seem to af-
fect the nucleosome structure and stability in different man-
ners, and may facilitate the oncogenic transformation of
cells.
MATERIALS AND METHODS
Purification of recombinant human histones
Human histones H2A (type 1-B/E), H2B (type 1-J), H3.1,
H4, H2A.Z.1, H2B E76K, H2A.Z.1 R80C and H3.1 E97K
were expressed and purified as described previously (19,20).
In vitro nucleosome reconstitution and purification
The H2A-H2B dimer, H2A-H2B E76K dimer, H2A.Z.1-
H2B-H3.1-H4 octamer, H2A.Z.1 R80C-H2B-H3.1-H4 oc-
tamer, H3.1-H4 tetramer andH3.1 E97K-H4 tetramer were
reconstituted with purified lyophilized histones, and the re-
constituted histone complexes were isolated by Superdex
200 gel filtration chromatography, as described previously
(21). For the nucleosome reconstitution, the purified H2A-
H2B dimer and the H3-H4 tetramer or the H2A.Z-H2B-
H3.1-H4 octamer were mixed with a 146 bp palindromic
-satellite DNA (1,21) in buffer containing 2 M KCl, and
the KCl concentration was gradually reduced to 0.25 M,
as previously described (21). The reconstituted nucleosomes
were further purified by preparative native polyacrylamide
gel electrophoresis (PAGE).
Crystallization and structure determination
The purified H2B E76K nucleosome, H2A.Z.1 R80C nu-
cleosome, and H2B wild-type nucleosome were dialyzed
against 20 mM potassium cacodylate (pH 6.0) buffer, con-
taining 1mM ethylenediaminetetraacetic acid (EDTA). For
crystallization, 1 l of the nucleosome samples (equivalent
to 3.0 g DNA/l) was mixed with 1 l of 20 mM potas-
sium cacodylate (pH 6.0) buffer, containing 50mMKCl and
110 mM MnCl2, and equilibrated against a reservoir solu-
tion of 20 mM potassium cacodylate (pH 6.0), 40 mMKCl
and 70 mM MnCl2. The crystals of the H2B E76K nucle-
osome and the H2B wild-type nucleosome were cryopro-
tected with a 30% polyethylene glycol 400 solution, contain-
ing 20 mM potassium cacodylate (pH 6.0), 36 mM KCl,
63 mM MnCl2 and 5% trehalose, and were flash-cooled
in liquid nitrogen. The X-ray diffraction data of the H2B
wild-type nucleosome were collected at the beamline BL1A
(wavelength: 1.10000 A˚) at the Photon Factory (Tsukuba,
Japan). The data of the H2B E76K nucleosome and the
H2A.Z.1 R80C nucleosome were collected at the beam-
line BL41XU (wavelength: 1.00000 A˚) at SPring-8 (Harima,
Japan). The diffraction data were scaled and processed us-
ing the HKL2000 and CCP4 programs (22,23). The struc-
tures of the nucleosomes were determined by the molecu-
lar replacement method, using the PHASER program (24).
For the H2B E76K nucleosome and the H2B wild-type
nucleosome, the human nucleosome structure (PDB ID:
2CV5) was used as the search model for molecular replace-
ment (25). For the H2A.Z.1 R80C nucleosome, the human
H2A.Z.1 nucleosome structure (PDB ID: 3WA9) was used
as the search model (26). The atomic coordinates were re-
fined using the PHENIX andCoot programs (27,28). Struc-
tural graphics rendering and root mean square deviation
(rmsd) value calculationswere performed using the PyMOL
program (http://pymol.org). The atomic coordinates of the
H2B E76K nucleosome, the H2A.Z.1 R80C nucleosome
and the H2B wild-type nucleosome have been deposited in
the Protein Data Bank, with the PDB IDs: 5Y0D, 5Z30 and
5Y0C, respectively.
Thermal stability assay of nucleosomes
The stabilities of the purified nucleosomes were evaluated
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This methodmonitors the fluorescence signal from SYPRO
Orange, which binds hydrophobically to the histones re-
leased from the nucleosome by thermal denaturation. The
thermal stability assay was performed in 19.6mMTris–HCl
(pH 7.5) buffer, containing 0.9 mM dithiothreitol (DTT),
100 mM NaCl and SYPRO Orange (x5). The nucleosome
concentrations were equivalent to 0.225 g DNA/l in the
experiments shown in Figures 2 and 6, and to 0.135 g
DNA/l in the experiments shown in Figure 7. The fluo-
rescence signals of the SYPRO Orange were detected with
a StepOnePlus Real-Time PCR unit (Applied Biosystems),
using a temperature gradient from 26 to 95◦C, in steps of
1◦C/min. Raw fluorescence data were adjusted to normal-
ized % values as (F(T) - F26◦C)/(F95◦C - F26◦C), where F(T),
F26◦C and F95◦C indicate each fluorescence at a particular
temperature, the fluorescence at 26◦C and the fluorescence
at 95◦C, respectively.
Nap1-mediated nucleosome formation assay
The purified H2A-H2B dimer or H2A-H2B E76K dimer
(1.5, 3 and 4.5 pmol) and H3.1-H4 tetramer (0.75, 1.5 and
2.25 pmol) were incubated with 11.25 pmol of humanNap1
at 37◦C for 15min, in 3.7l of reaction solution. The pBlue-
script plasmid DNA containing eleven 5S repeats (5276 bp,
29 fmol), which was previously incubated with 1.7 units of
calf thymus topoisomerase I (Takara) at 37◦C for 60 min,
was then added to the reaction mixture. The reactions were
continued at 37◦C for 60min in 11mMTris–HCl buffer (pH
7.5), containing 84 mM NaCl, 0.43 mM MgCl2, 1.2 mM
DTT, 0.73 mM EDTA, 1.4 mM 2-mercaptoethanol, 0.01
mM phenylmethylsulfonyl fluoride (PMSF) 0 and 1% glyc-
erol (total volume: 4.7l). The reaction solutions were incu-
bated with 2 l of a proteinase K solution (1.67% sodium
dodecyl sulphate (SDS) and 9.3 mg/ml proteinase K) for
15 min at room temperature, and the reactions were termi-
nated. TheDNA samples were then analyzed by 1% agarose
gel electrophoresis in 1× Tris-acetate-EDTA (TAE) buffer,
and were visualized by SYBR Gold staining (Invitrogen).
Gel filtration analysis
Purified H2A, H2B (or H2B E76K), H3.1 (or H3.1 E97K)
and H4 were mixed and denatured in a 7 M guanidine hy-
drochloride solution, containing 20 mM Tris–HCl (pH 7.5)
and 20 mM 2-mercaptoethanol, at 4◦C for 60 min. In the
gel filtration experiments, 1.3-fold excess amounts of H2A
andH2Bwere used. The samples were then dialyzed against
10 mM Tris–HCl buffer (pH 7.5), containing 2 M sodium
chloride, 1 mM EDTA and 5 mM 2-mercaptoethanol. Af-
ter this dialysis step, the samples were subjected to gel filtra-
tion chromatography on a Superdex 200 pg 26/600 column
(GEHealthcare). The peak fractions were analyzed by 18%
SDS-PAGE with Coomassie Brilliant Blue (CBB) staining.
Fluorescence recovery after photobleaching (FRAP) analysis
The DNA fragment encoding green fluorescent protein
(GFP)-fused H2B (HIST1H2BJ), H2B E76K, H3.1, or
H3.1 E97K was inserted between the NheI and BamHI
sites of the PB533A-2 vector (System Biosciences). The
DNA fragment encoding GFP-fused H2A.Z.1 or H2A.Z.1
R80C was inserted between the NheI and BamHI sites
of the PB510B-1 vector (System Biosciences). To estab-
lish the cells expressing GFP-H2B and GFP-H2B E76K,
HeLa cells expressing proliferating cell nuclear antigen
(PCNA)–mCherry were transfected with a Tn5-expression
vector (System Biosciences) and either PB533A-2-GFP-
H2B or PB533A-2-GFP-H2B E76K, using Lipofectamine
2000 (Thermo Fisher Scientific). To establish the cells ex-
pressing GFP-H3.1, GFP-H3.1 E97K, GFP-H2A.Z.1 and
GFP-H2A.Z.1 R80C, HeLa cells were transfected with
a Tn5-expression vector and either PB533A-2-GFP-H3.1,
PB533A-2-GFP-H3.1 E97K, PB510B-1-GFP-H2A.Z.1 or
PB510B-1-GFP-H2A.Z.1 R80C. HeLa cells were cultured
as described previously (31). GFP-positive cells were sorted
using a cell sorter, SH800Z (Sony). Fluorescence recov-
ery after photobleaching (FRAP) was performed by the
method described previously (31,32). For the cells express-
ing GFP-H2B, GFP-H2B E76K, GFP-H2A.Z.1 and GFP-
H2A.Z.1 R80C, images were acquired every 1 min from 2
min before photobleaching to 60 min after photobleach-
ing in the presence of 20 ng/ml cycloheximide (to moni-
tor the exchange without the effect of newly synthesized
protein molecules). For the cells expressing GFP-H3.1 or
GFP-H3.1 E97K, images were acquired every 0.078–0.4 s,
and the relative intensity was measured at ∼−2.0, −1.0,
−0.0, 0.1, 0.3, 0.6, 1.0, 2.0, 3.0 and 4.0 s after bleaching.
To obtain the relative intensities of the bleached area, the
net intensities of the bleached areas (after background sub-
traction) were normalized to the net intensities of the un-
bleached areas in each time frame. The relative intensities in
each time frame were then normalized to the intensity be-
fore bleaching. The half-lives of GFP-H2B and GFP-H2B
E76K were calculated by fitting the FRAP curves of sin-
gle cells to the exponential recovery curve, using Image J
(1.47v). The box plot was generated using the BoxPlotR
tool (http://shiny.chemgrid.org/boxplotr/).
Quantification of GFP-H2B or GFP-H2B E76K in HeLa
cells
The whole cell extracts of the HeLa cells producing PCNA–
mCherry and either GFP-H2B or GFP-H2B E76K were
prepared to yield 7.5 × 106 cell equivalents per ml using
100mMTris–HCl (pH 6.8) buffer, containing 4% SDS, 20%
glycerol and 0.2 M DTT. Three whole cell lysates (#1-#3)
were independently prepared from HeLa cells producing
GFP-H2B andGFP-H2BE76K. To estimate the amount of
endogenous H2B, the whole cell lysates (5 × 104 cell equiv-
alents) were analyzed by SDS-PAGE. The proteins were vi-
sualized by CBB staining. The calibration curve was ob-
tained by the band intensities of purified recombinant H2B
(50, 100, 200 and 400 ng), as the standard protein. To es-
timate the amount of GFP-H2B or GFP-H2B E76K, the
whole cell lysates (3× 104 cell equivalents) were analyzed by
SDS-PAGE, followed by western blotting. The calibration
curve was obtained by the band intensities of purified re-
combinantGFP-H2B (10, 20, 30 and 40 ng), as the standard
protein. The GFP was detected by an ECL Western Blot-
ting Detection System (GE Healthcare Biosciences), using
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anti-GFP rabbit polyclonal antibody (sc-8334, Santa Cruz
Biotechnology) and the peroxidase-conjugated anti-rabbit
IgG (NA9340, GEHealthcare Biosciences) were used as the
primary and secondary antibodies, respectively. The band
intensity was quantified using the Multi Gauge software
(Fujifilm).
Composition of nucleosomes containing GFP-tagged his-
tones in HeLa cells
The composition of nucleosomes containing GFP-tagged
histones was analyzed as previously described (33).
HeLa cells producing GFP-H2B, GFP-H2B E76K, GFP-
H2A.Z.1 orGFP-H2A.Z.1 R80Cwere harvested and lysed,
using a homogenizer. The insoluble fractions of the cell
lysates were collected by centrifugation, and were digested
with micrococcal nuclease (MNase, New England Biolabs)
in 15 mM HEPES-NaOH (pH 7.4) buffer, containing 15
mM NaCl, 60 mM KCl, 340 mM sucrose, 1 mM CaCl2,
0.5 mM spermidine and 0.15 mM spermine, for 60 min at
30◦C. After the MNase digestion, the insoluble fraction
was collected by centrifugation and was suspended in a
500 mM NaCl solution containing 9 mM EDTA. The
MNase-digested chromatin was then solubilized and those
containing the GFP-fused histones were purified using
GFP-Trap MA beads (ChromoTek). After the separation
by SDS-PAGE and agarose gel electrophoresis, proteins
and DNA were detected with CBB and GelRed (Biotium),
respectively.
Colony formation assay
The DNA fragment encoding wild-type human H2B
(HIST1H2BJ), H2B E76K, H3.1, H3.1 E97K, H2A.Z.1
or H2A.Z.1 R80C was inserted just downstream of the
CAG promoter in pCAGGS, and the Internal Ribosome
Entry Site (IRES) was placed downstream of each his-
tone gene. The DNA fragment encoding GFP was then
inserted downstream of IRES (pCAGGS-H2B E76K-
IRES-GFP, pCAGGS-H2B-IRES-GFP, pCAGGS-H3.1-
IRES-GFP, pCAGGS-H3.1 E97K-IRES-GFP, pCAGGS-
H2A.Z.1-IRES-GFP or pCAGGS-H2A.Z.1 R80C-IRES-
GFP). NIH3T3 cells were cultured in DMEM contain-
ing antibiotics (100 U/ml penicillin and 100 g/ml strep-
tomycin) and 10% Fetal bovine serum (FBS), and were
transfected with these plasmids by the Nucleofector system
(Lonza). At 40 h after transfection, about 500 cells were
seeded onto 100-mm tissue culture dishes, and incubated for
10 days at 37◦C, in a 5% CO2 atmosphere. After the incuba-
tion, the dishes were washed with PBS and stained with 4%
Giemsa. Colonies containing over 50 cells were counted.
For the western blotting analysis, NIH3T3 cells were har-
vested at 48 h after transfection. The cells were washed with
ice-cold PBS and lysed with RIPA buffer (10 mM Tris–
HCl (pH 7.4), 150 mM sodium chloride, 5 mM EDTA, 1%
Triton X-100 (Sigma-Aldrich), 1% sodium deoxycholate,
0.1% SDS and 0.2 mM PMSF). The cells were lysed by
freezing and thawing, and after centrifugation, the super-
natants were analyzed by western blotting. The GFP and
-actin were detected by an ECL Western Blotting Detec-
tion System (GE Healthcare). For the GFP detection, the
anti-GFP rabbit polyclonal antibody (sc-8334, Santa Cruz
Biotechnology) and the peroxidase-conjugated anti-rabbit
IgG (NA934, GE Healthcare) were used as the primary
and secondary antibodies, respectively. For the -actin de-
tection, the anti--actin mouse monoclonal antibody (013-
24553, Wako) and the peroxidase-conjugated anti-mouse
IgG (NA931, GEHealthcare) were used as the primary and
secondary antibodies, respectively.
Cell cycle analysis
NIH3T3 cells (1.0 × 106) were transfected with pCAGGS-
H2B E76K-IRES-GFP or pCAGGS-H2B-IRES-GFP by
the Nucleofector system (Lonza), and were cultured in
DMEM containing antibiotics (100 U/ml penicillin and
100 g/ml streptomycin) and 10% FBS at 37◦C, in a 5%
CO2 atmosphere. At 40 h post-transfection, the cells were
harvested and treated with 70% cold ethanol. After wash-
ing the cells with 1.5 ml of PBS, RNaseA (1.5 mg, SIGMA)
was added, and the cells were incubated for 30 min at room
temperature. After the RNaseA treatment, the cells were
stained with propidium iodide (75 g, SIGMA) for 30 min
on ice. The propidium iodide intensity of each single cell
was quantified by a flow cytometry system, BD FACS Cal-
ibur (BD Biosciences). The DNA content data for 100,000
cells were analyzed, and histograms were obtained using the
FCS Express 6 software (De Novo Software).
Cell growth analysis
NIH3T3 cells (1.0 × 106) were transfected with pCAGGS-
IRES-GFP, pCAGGS-H2B E76K-IRES-GFP, pCAGGS-
H2B-IRES-GFP, pCAGGS-H3.1-IRES-GFP, pCAGGS-
H3.1 E97K-IRES-GFP, pCAGGS-H2A.Z.1-IRES-GFP or
pCAGGS-H2A.Z.1 R80C-IRES-GFP by the Nucleofector
system (Lonza), and were cultured in DMEM containing
antibiotics (100 U/ml penicillin and 100 g/ml strepto-
mycin) and 10% FBS at 37◦C, in a 5% CO2 atmosphere. At
40 h post-transfection, the cells were harvested. The cells
(2 × 104) were seeded onto 35-mm tissue culture dishes,
and were incubated at 37◦C, in a 5% CO2 atmosphere. The
cells were harvested every 24 h for 7 days from independent
dishes, and the cell numbers were manually counted.
RESULTS
The H2B E76K mutation changes the nucleosome structure
at the interface between H2B and H4
Somatic missense mutations in canonical H2B genes have
been reported in several types of cancer cells (13–15).
We obtained the somatic mutation data for seventeen
H2B genes (HIST1H2BB, HIST1H2BC, HIST1H2BD,
HIST1H2BE, HIST1H2BF, HIST1H2BG, HIST1H2BH,
HIST1H2BI, HIST1H2BJ, HIST1H2BK, HIST1H2BL,
HIST1H2BM,HIST1H2BN,HIST1H2BO,HIST2H2BE,
HIST2H2BF and HIST3H2BB) from the cBioPortal for
Cancer Genomics database (34,35), and found that muta-
tions of the H2B Glu76 residue occur with high frequency,
implying that the H2B Glu76 mutations may be involved
in cancer progression (Supplementary Figure S1). Among
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Figure 1. Crystal structure of the H2B E76K nucleosome. (A) Left panel: overall structure of the H2B E76K nucleosome. The H2A, H2B E76K, H3.1 and
H4molecules are colored yellow, pink, blue and green, respectively. Right panel: close-up view around the Lys76 residue of H2B E76K. (B) The H2B E76K
substitution significantly changed the backbone geometry aroundArg92 ofH4. The rootmean square deviation (r.m.s.d.) values between the corresponding
C atoms of the H2B E76K and wild-type H2B molecules in the nucleosomes are plotted against the amino acid residues. Two H2A molecules (chains
C and G), two H2B molecules (chains D and H), two H3.1 molecules (chains A and E) and two H4 molecules (chains B and F) in the nucleosomes were
independently compared. (C) The structures around the H2B Lys76 residue of the nucleosomes. The H4 and H2B molecules in the H2B E76K nucleosome
are colored green and pink, respectively. The H4 and H2B molecules in the wild-type H2B nucleosome are colored gray. The structures of the H2B E76K
and wild-type H2B nucleosomes are superimposed. (D–F) Close-up views of the Lys76 residue of H2B E76K (D), the Arg92 residue of H4 (E) and the
Tyr83 residue of H2B E76K (F) in the H2B E76K nucleosome. Electron density maps are presented at the 1.0 level.
the Glu76 residue is replaced by Lys, is the predominant
substitution. If the H2B E76K mutation within one of
the seventeen H2B genes is involved in cancer progression,
then the presence of the H2B E76K mutant contaminating
large amounts of wild-typeH2Bmay dominantly induce the
oncogenic transformation.
To study the effect of the H2B E76K mutation on the
structure of the nucleosome, we first purified theH2BE76K
mutant, and found that it was efficiently incorporated into
nucleosomes (Supplementary Figure S2). The crystal struc-
ture of the H2B E76K nucleosome was then determined at
1.99 A˚ resolution (Figure 1A and Supplementary Table S1).
For comparison, we also determined the canonical nucle-
osome structure containing wild-type H2B with a similar
resolution, at 2.09 A˚ (Supplementary Table S1).
We superimposed the H2B E76K nucleosome structure
on the wild-type H2B nucleosome structure, and compared
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Figure 2. TheH2B E76K nucleosome is extremely unstable. (A) Schematic
representation of the nucleosome thermal stability assay. In this assay, the
histones that thermally dissociate from the nucleosome are detected with
SYPRO Orange, as a fluorescent probe. In the first step, H2A-H2B disso-
ciates from the nucleosome and is detected by the fluorescence of SYPRO
Orange. In the second step, H3-H4 dissociates from the nucleosome and
is detected in a similar manner. (B) Thermal stability assay with the H2B
wild-type and H2B E76K nucleosomes. The upper panel shows the ther-
mal stability curves of the H2B wild-type (black) and H2B E76K (red)
nucleosomes. The bottom panel shows the differential values of the ther-
mal stability curves presented in the upper panel. Means ± s.d. (n = 3) are
shown.
values of the corresponding C atoms between the H2B
E76K and wild-type nucleosomes were plotted (Figure 1B).
Two histone peptides for H2A (chains C and G), H2B
(chains D and H), H3.1 (chains A and E) and H4 (chains
B and F) in the crystal structures were independently com-
pared. We found that the H2B E76K mutation did not af-
fect the backbone geometries of H2B, H2A and H3.1 in
the nucleosome (Figure 1B, first, second and third rows).
However, surprisingly, the H2B E76K substitution signif-
icantly changed the backbone geometry around Arg92 of
H4 (Figure 1B, bottom row). In fact, in the H2B E76K nu-
cleosome, the H2B Lys76 side chain caused electrostatic re-
pulsion with the H4 Arg92 residue, and drastically changed
the configuration of the H4 3-helix (Figure 1C–E). Inter-
estingly, the stacking interaction of the side chain moieties
between theH2BTyr83 andH4 Tyr88 residues was alloster-
ically perturbed by the H2B E76K substitution (Figure 1C
and F). Therefore, the H2B E76K mutation substantially
changes the interaction between H2B and H4 within the
nucleosome, and this modified H2B–H4 interaction may
destabilize the H2B E76K nucleosome.
The H2B E76K nucleosome is unstable
We then performed a thermal stability assay (Figure 2A),
in which the histones that thermally dissociate from the nu-
cleosome are detected with SYPRO Orange, as a fluores-
cent probe (29,30). In the wild-type nucleosome, the two-
step histone dissociation is detected as a bi-phasic ther-
mal denaturation curve, in which the first and second peaks
correspond to the H2A-H2B dissociation and the H3-H4
dissociation, respectively (Figure 2B). Intriguingly, in the
H2B E76K nucleosome, the H2A-H2B E76K dissociation
(first peak) occurred at a remarkably lower temperature
Figure 3. The H2A-H2B E76K dimer is defective in H3-H4 binding. (A)
Superdex 200 gel filtration chromatography. The red line indicates the elu-
tion profile of the H2A-H2B E76K dimer and the H3-H4 tetramer. The
black line indicates the elution profile of theH2A-H2Bdimer and theH2A-
H2B-H3-H4 complexes. (B andC) SDS-PAGE analyses of the elution frac-
tions from the gel filtration chromatography shown in panel A. The experi-
ments with wild-typeH2B andH2BE76K are presented in panels B andC,
respectively. The gels were stained with CBB. The full gel images of Figure
3B and C are shown in Supplementary Figures S13A and B, respectively.
(∼10◦C difference), as compared to the H2A-H2B dissoci-
ation in the wild-type nucleosome (Figure 2B). In contrast,
the H3-H4 dissociation (second peak) occurred at the same
temperature between the H2B E76K and wild-type nucle-
osomes (Figure 2B). These results indicated that the H2A-
H2B E76K complexes are weakly associated in the nucleo-
some.
The H2A-H2B E76K dimer does not bind to the H3-H4 com-
plex without DNA
We then assessed the interaction between H2A-H2B and
H3-H4 by gel filtration chromatography. As shown in Fig-
ure 3A (the chromatogram with the black line), wild-type
H2A-H2B bound to H3-H4 in the absence of DNA, and
efficiently formed the histone complex corresponding to
the histone octamer or hexamer (Figure 3B). In contrast,
the peak corresponding to the histone octamer or hex-
amer was not detected, when H2A-H2B E76K was incu-
bated with H3-H4 (Figure 3A, the chromatogram with the
red line, and Figure 3C). These results clearly showed that
H2A-H2B E76K is defective in binding to H3-H4 without
DNA. Therefore, the defective interaction between H2A-
H2B E76K and H3-H4 may be responsible for the insta-
bility of the H2B E76K nucleosome.
H2B E76K is incorporated into chromatin and rapidly ex-
changed in living cells
We next produced H2B E76K as a GFP-fusion protein in
living cells, to compare its exchange rate with that of the
wild-type H2B by FRAP (32). In stably expressing HeLa
cells, the levels of GFP-H2B E76K and GFP-H2B were es-
timated to be ∼9% and ∼14% of the endogenous H2B, re-
spectively (Supplementary Figure S3A and B). Similar to
the wild-type H2B, GFP-H2B E76K was concentrated in
interphase nuclei and in mitotic chromosomes (Supplemen-
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tually incorporated into nucleosomes in HeLa cells, we per-
formed a micrococcal nuclease digestion followed by im-
munoprecipitation, using anti-GFP nanobody beads (Sup-
plementary Figure S4A and B). GFP-H2B E76K was re-
covered in the nucleosome fraction, and the stoichiometry
of endogenous H2B was lower in the nucleosomes contain-
ingGFP-H2BE76K, as in those containingGFP-H2B, sug-
gesting that H2B E76K is properly incorporated into chro-
matin. To examine whether the H2B E76K mutant can be
assembled into nucleosomes by a histone chaperone in vitro,
we performed a nucleosome assembly assay with the promi-
nent histone chaperone, Nap1 (Supplementary Figure S5A)
(36). As expected, the H2B E76K mutant was incorporated
into the nucleosomes; however, we reproducibly observed
that the nucleosome formation with the H2B E76K mu-
tant was subtly reduced, as compared to that with the wild-
type H2B (Supplementary Figure S5B and C). We then per-
formed FRAP by bleaching one-half of each nucleus (Fig-
ure 4A). The first point after bleaching was higher in H2B
E76K than thewild type and the recovery kinetics was faster
in the mutant (Figure 4B–D), indicating that H2B E76K is
exchanged more rapidly than wild-type H2B. Thus, the nu-
cleosome containing H2B E76K is also less stable than the
wild-type H2B in living cells, in good agreement with the in
vitro biochemical properties.
Exogenous H2B E76K production affects colony formation
ability of cells
We then producedH2BE76K or wild-typeH2B inNIH3T3
cells by transient transfection. At 10 days post-transfection,
the colony number of the cells producing H2B E76K was
higher than that of the cells producing wild-type H2B (Fig-
ure 5A and B). To test whether the H2B E76K mutation
caused abnormal cell cycle progression, we measured the
DNA content of an asynchronous population of the cells
producing H2B E76K by flow cytometry, as previously re-
ported for yeast histone mutants (37–39). The cells produc-
ing H2B E76K did not exhibit abnormal cell cycle progres-
sion, suggesting that this mutation did not drastically af-
fect the cell-cycle progression (Supplementary Figure S6A).
Consistently, the growth rate of the cells was not affected by
the expression of the H2B E76K mutant (Supplementary
Figure S6B). These results indicated that the production of
the H2B E76K mutant promotes an oncogenic-like trans-
formation, with reduced contact inhibition and enhanced
colony formation ability, although the growth rate of the
cells is not significantly affected. Thismay explain the domi-
nant negative phenotype of theH2BE76Kmutation in can-
cer cells. In this system, the mRNA encoding H2B E76K
or wild-type H2B was expressed together with an mRNA
encoding GFP as polycistronic genes, and stoichiometric
amounts of exogenous H2B and GFP were produced in
the cells. Therefore, the exogenous H2B production can be
monitored as the GFP signal in cells. Similar amounts of
GFP were detected in the cells expressing H2B E76K and
wild-type H2B (Figure 5C), confirming that the production
levels of H2B E76K and wild-type H2B were not substan-
tially different in these cells.
Figure 4. Mobility of GFP-H2B E76K in living cells. (A) Representative
fluorescence images of HeLa cell nuclei producing GFP-H2B or GFP-
H2B E76K, before and after photobleaching. One-half of the nuclei were
bleached using a 488-nm laser. Bars, 10 m. (B) Relative fluorescence in-
tensity of the bleached area, normalized by the unbleached areas. Inten-
sities were obtained from 2 min before photobleaching to 60 min after
photobleaching. Averages with standard deviations are plotted (n = 28
and 22 for GFP-H2B and GFP-H2B E76K respectively). (C) The half-
lives of GFP-H2B and GFP-H2B E76K were estimated from the averages
of FRAP curves of 26 and 14 cells for GFP-H2B and GFP-H2B E76K,
respectively. (D) Box plots of the half-lives of GFP-H2B and GFP-H2B
E76K FRAP curves.
Somatic missense mutations, H3.1 E97K and H2A.Z.1
R80C, destabilize the nucleosome
It is intriguing to investigate whether the nucleosome-
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Figure 5. Exogenous H2B E76K production enhances malignant trans-
formation of cells. (A) Colony formation assay with NIH3T3 cells express-
ing H2B or H2B E76K. Representative images are shown. Three indepen-
dent experiments were performed, and similar results were obtained. (B)
Graphic representation of the experiments shown in panel A. The colony
numbers of cells expressing H2B or H2B E76K are plotted. Means ± s.d.
(n = 3) are shown. (C) Western blotting analyses. The production of ex-
ogenous H2B and H2B E76K was detected by western blotting, using the
-GFP polyclonal antibody (upper panel). In this system, GFP was simul-
taneously produced with H2B or H2B E76K, from a polycistronic gene.
For loading controls, endogenous -actin was detected by western blot-
ting using the anti--actin antibody (lower panel). The full images of the
western blots are shown in Supplementary Figures S13C and D.
common in other canonical histone mutations. We inves-
tigated the somatic mutation data for canonical histone
genes in the cBioPortal for Cancer Genomics database
(34,35). We searched the somatic mutation data for ten H3
genes (HIST1H3A, HIST1H3B, HIST1H3C, HIST1H3D,
HIST1H3E, HIST1H3F, HIST1H3G, HIST1H3H,
HIST1H3I and HIST1H3J), and found that mutations of
the H3 Glu97 residue occur with high frequency, similar to
the H2B Glu76 mutations (Supplementary Figure S1). We
prepared the H3 E97K mutant, and found that H3 E97K
efficiently formed nucleosomes (Supplementary Figure
S7). Our thermal stability assay revealed that the H3 E97K
nucleosome exhibited a monophasic dissociation profile,
and thus the H3 E97K-H4 dissociation may simultaneously
occur with the H2A-H2B dissociation (Figure 6A). This
indicated that the H3 E97K nucleosome was substantially
unstable, as compared to the wild-type nucleosome. Inter-
estingly, a gel filtration chromatographic analysis indicated
that H3 E97K-H4 is defective in binding to H2A-H2B
without DNA (Figure 6B–D). Our in vivo assays revealed
that the H3 E97K mutant was minimally incorporated
into chromosomes in cells (Figure 6E and F). However,
the H3 E97K mutant slightly, but clearly, enhanced the
colony formation ability of the cells (Supplementary Figure
S8), although the growth rate of the cells was not affected
(Supplementary Figure S9A). The H3 E97K mutant may
compete with wild-type H3.1, and may perturb the proper
function of H3.1. Further studies will be required to
understand how the H3 E97K mutant enhances the colony
formation ability of the cells.
To test whether the unstable nucleosome character by
the cancer-associated mutations is common to histone vari-
ants, we searched the cBioPortal for the H2AFZ gene, a
prominent histone variant (34,35). We found the H2A.Z.1
R80C mutant, in which the Arg80 residue is replaced by
cysteine, as a cancer-associated somatic mutation (Supple-
mentary Figure S1). We reconstituted the nucleosome con-
taining the H2A.Z.1 R80C mutant (Supplementary Fig-
ure S10). The H2A.Z.1 R80C nucleosome migrated more
slowly than the wild-type H2A.Z.1 nucleosome on a na-
tive polyacrylamide gel (Supplementary Figure S10A). A
similar unusual gel mobility profile was observed for the
H3 E97K nucleosome (Supplementary Figure S7A). These
results suggest that, as in the H3 E97K nucleosome, the
physical characteristics of the H2A.Z.1 R80C nucleosome
are different from those of the wild-type H2A.Z.1 nucleo-
some. Consistent with this idea, the nucleosome contain-
ing H2A.Z.1 R80C was clearly unstable, as compared to
the wild-type H2A.Z.1 nucleosome (Figure 7A). However,
in contrast to the H3 E97K mutant, the H2A.Z.1 R80C
mutant was incorporated into chromatin in cells (Figure
7E and Supplementary Figure S11). The mobility of the
H2A.Z.1 R80Cmutant was slightly faster than that of wild-
type H2A.Z.1, but the H2A.Z.1 R80C production did not
affect the cell growth and colony formation ability of the
cells (Supplementary Figures S8 and 9). The crystal struc-
ture of the H2A.Z.1 R80C nucleosome revealed that the
H2A.Z.1 Arg80 residue is located near the DNA backbone,
and the local structure around the H2A.Z.1 R80 residue is
changed by the R80C mutation (Figure 7B–D and Supple-
mentary Figure S12). The perturbation of the local DNA–
histone interaction induced by theH2A.Z.1R80Cmutation
may be the structural basis for the nucleosome instability.
DISCUSSION
In the present study, we determined the crystal structure of
the nucleosome containing the H2B E76K mutant at 1.99
A˚ resolution (Figure 1). This high-resolution analysis of
the H2B E76K nucleosome structure revealed the detailed
structural differences from the canonical nucleosome. We
surprisingly found that only one amino acid substitution,
at the H2B Glu76 residue, drastically perturbs the local hi-
stone interactions between the H2B 2 and H4 3 helices
within the nucleosome (Figure 1). Consistently, biochemi-
cal analyses revealed that the H2B E76K mutation reduces
the interaction between H2A-H2B and H3-H4, and desta-
bilizes the nucleosome (Figures 2 and 3).
The H2B Glu76 residue is frequently mutated in cancer
cells (34,35). Therefore, the H2B E76K-mediated structural
change may induce the oncogenic transformation in cells
producing H2B E76K. We found that the H2B E76K mu-
tant is efficiently incorporated into chromatin in cells (Fig-
ure 4; Supplementary Figures S3 and 4), and the produc-
tion of the H2B E76K mutant transforms the cells (Fig-
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Figure 6. The H3.1 E97K mutation destabilizes the nucleosome and the histone complex. (A) Thermal stability assays of the H3.1 wild-type and H3.1
E97K nucleosomes. The upper panel shows the thermal stability curves of the H3.1 wild-type (black) and H3.1 E97K (red) nucleosomes. The bottom
panel shows the differential values of the thermal stability curves presented in the upper panel. Means ± s.d. (n = 3) are shown. (B) Superdex 200 gel
filtration chromatography. The red line indicates the elution profile of the H2A-H2B dimer and the H3.1 E97K-H4 tetramer. The black line indicates the
elution profile of the H2A-H2B dimer and the H2A-H2B-H3-H4 complexes. (C andD) SDS-PAGE analyses of the elution fractions from the gel filtration
chromatography shown in panel B. The experiments with wild-type H3.1 and H3.1 E97K are presented in panels C and D, respectively. The gels were
stained with CBB. The full gel images of Figure 6C and D are shown in Supplementary Figure S13E and F, respectively. (E) Localization of GFP-H3.1
and GFP-H3.1 E97K in interphase and mitotic HeLa cells. Fluorescent (GFP) and bright-field (BF) images are shown with the merged images (merge).
GFP-H3.1 E97K does not localize to the mitotic chromosomes. Bars, 10 m. (F) Photobleaching assay. Bleaching a half of nucleus as in Figure 4 resulted
in loss of fluorescence in GFP-H3.1 E97K because of a long bleaching period, during which free molecules are in and out of the bleached area. Therefore, a
rapid imaging and bleaching assay was employed to evaluate the incorporation of GFP-H3.1 proteins. The relative intensity of bleached area was measured
at ∼−2.0, −1.0, −0.0, 0.1, 0.3, 0.6, 1.0, 2.0, 3.0 and 4.0 s after bleaching. Averages with standard deviations are plotted (n = 17 and 15 for GFP-H3.1 and
GFP-H3.1 E97K, respectively). The intensity of GFP-H3.1 E97K recovered to almost the original level within a few seconds, indicating that this H3.1
mutant is not stably incorporated into nucleosomes. A substantial recovery of wild-type H3.1 with a huge deviation was also observed. This high cell-to-cell
variation of the rapidly recovered fraction likely reflects the amount of free GFP-H3.1 in cells at different cell cycle stages, as reported previously (32).
the H2B E76K incorporation contribute to the oncogenic
transformation of cells? One plausible explanation is that
the unstable H2B E76K nucleosomemay disturb the proper
chromatin-mediated regulation of genomicDNA functions.
This idea may be supported if other cancer-associated his-
tonemutations also form unstable nucleosomes. In this con-
text, we found that the cancer-associated R80Cmutation of
a major histone variant, H2A.Z.1, destabilizes the nucleo-
some (Figure 7A), although the colony formation ability of
the cells producingH2A.Z.1 R80C seemed to be slightly en-
hanced (Supplementary Figure S8).
Another cancer-associated mutant of histone H3.1, H3.1
E97K, also destabilizes the nucleosome (Figure 6). The
colony formation ability of the cells producing H3.1 E97K
was enhanced (Supplementary Figure S8). However, the
H3.1 E97Kmutant may affect the cells by a different mech-
anism from that of the H2B E76K mutant, because it is
not efficiently incorporated into chromatin in cells (Figure
6E and F). The H3.1 E97K mutant may inhibit the proper
function of wild-type H3.1, probably by competing with in-
teractions with the histone assembly complexes and/or his-
tone chaperones, prior to the H3.1 deposition into the chro-
matin. Further studies are awaited to clarify this issue.
Mutations of the Lys27, Gly34 and Lys36 residues in
the histone variant H3.3 have been reported in pediatric
gliomas and chondroblastomas (7–9). The H3.3 Lys27,
Gly34 and Lys36 residues, which are located in the N-
terminal tail region, are highly conserved among histone
variants, and are exposed to the solvent in the nucleosome
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Figure 7. The H2A.Z.1 R80C mutation destabilizes the nucleosome. (A)
Thermal stability assay with the H2A.Z.1 wild-type and H2A.Z.1 R80C
nucleosomes. The upper panel shows the thermal stability curves of the
H2A.Z.1 wild-type (black) and H2A.Z.1 R80C (red) nucleosomes. The
bottom panel shows the differential values of the thermal stability curves
presented in the upper panel. Means ± s.d. (n = 3) are shown. (B) Overall
crystal structure of the H2A.Z.1 R80C nucleosome. The H2A.Z.1 R80C,
H2B, H3.1 and H4 molecules are colored red, orange, light blue and
light green, respectively. (C) A close-up view around the Cys80 residue of
H2A.Z.1 R80C in the H2A.Z.1 R80C nucleosome. (D) A close-up view
around the Arg80 residue of H2A.Z.1 in the H2A.Z.1 wild-type nucle-
osome (PDB ID: 3WA9) (26). (E) Relative fluorescence intensity of the
bleached area, normalized by the unbleached areas. Intensities were ob-
tained from 2 min before photobleaching to 60 min after photobleaching.
Averages with standard deviations are plotted (n = 24 and 20 for GFP-
H2A.Z.1 and GFP-H2A.Z.1 R80C, respectively).
the nucleosome structure and stability, and instead mainly
function as binding sites for histone binding proteins, such
as the histone modifiers and readers for post-translational
modifications (10–12). In fact, our crystallographic analyses
revealed that the mutations of these residues did not affect
the structure of the nucleosome (data not shown). In con-
trast, we found that theH2BE76K andH2A.Z.1 R80Cmu-
tations substantially change the nucleosome structure and
stability. In addition, our preliminary structural analysis of
the nucleosome containing the H3.1 E97K mutation sug-
gested that this nucleosome is structurally different from
the wild-type nucleosome, as revealed by a small angle X-
ray scattering analysis (data not shown). Therefore, the hi-
stone mutations found in the histone-fold domain may af-
fect the cell fate in different pathways from the mutations in
the N-terminal tail regions. The defective histone–histone
or histone–DNA interaction inducing nucleosome instabil-
ity may be a common characteristic for a certain group of
cancer-associated histone mutations located in the histone-
fold domain.
Recent evidence has suggested that specific chromatin
structures, formed with certain histone modifications and
variants, may play a central role in the epigenetic regula-
tion of genomic DNA (10,17,18,42,43). The distributed in-
corporation of the H2A-H2B E76K and H2A.Z.1 R80C-
H2B dimersmay disturb such chromatin-mediated genomic
DNA regulation. In general, nucleosomes negatively impact
transcription (44,45). The disseminated H2B E76K and
H2A.Z.1 R80C incorporation, which destabilizes the nu-
cleosome, may reduce the nucleosome barrier during tran-
scription processes throughout the genome. Such global
de-suppression of transcription may induce the undesired
expression of oncogenes, which are usually suppressed by
chromatin, and potentially stimulate cancer progression.
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